Skip to main content

Table 2 The results of laboratory findings

From: Increased pulmonary embolism in patients with COVID-19: a case series and literature review

Test Name

Unit

Reference Range

Case 1

Case 2

Case 3

BUN

mg/dl

7–16.8

24 Hi

28 Hi

20

Ca

mg/dl

8.6–10.3

8.5 Low

–

–

p

mg/dl

2.7–4.5

4.9 Hi

–

–

Na (ser)

mEq/L

138–145

139

139

140

K (ser)

mEq/L

3.6–5.9

4.3

4.3

3.7

MCH

pg

27.5–33.2

28.2

28.2

32.5

MCHC

g/dL

30.0–38.0

34.6

31.6

32.6

Plt

× 1000/μL

140–440

252

167

72

Cr

mg/dl

male:0.8–1.3 mg/dl

1

1.1

1.4 Hi

SGOT (AST)

IU/L

Male:< 40

86 Hi

109 Hi

–

SGPT (ALT)

IU/L

Male:< 45

46 Hi

55 Hi

–

WBC

×1000/μL

4.4–11

3.5 Low

8.6

8

RBC

×1,000,000/μL

male:4.5–6.5

4.25 Low

4.04 Low

4.19 Low

Hb

g/dl

male:14–17

12 Low

14.2

13.6 Low

Hct

%

male:41.5–50.4

34.7 Low

45.0

41.7

MCV

fl

80–96

81.6

89.3

99.5

ALK.P

IU/L

Male:0–270

617 Hi

280 Hi

–

CRP

mg/L

0–6

–

65 Hi

–

ESR

mm

5–12

–

55 Hi

–

D-Dimer

ng/ml

Normal< 200

–

< 200

–

CPK

IU/L

Male:0–171

617 Hi

–

350 Hi

LDH

U/L

Male:235–470

810 Hi

–

650 Hi

Troponin 1

  

Negative

–

Negative

BS

mg/dl

 

126

–

127

P.T.T

sec

26–38 s

29

–

30

PT

 

11–13 s

13.6

–

15

INR

  

1.2

–

1.6

PT Control

%

 

12

–

11

Amylase

IU/L

< 100 U/L

98

–

–

HBSAg CLIA

MIU/ml

< 1 non reactive> = 1 reactive

Negative

Negative

Negative

HCV-Ab CLIA

MIU/ml

< 1 non reactive> = 1 reactive

Negative

Negative

Negative

HIV-Ab CLIA

MIU/ml

< 1 non reactive> = 1 reactive

Negative

Negative

Negative